Novo Nordisk A/S - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US6701002056

SecurityNVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionAxa S.a.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Axa S.a. closes position in NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On November 14, 2025 - Axa S.a. filed a 13F-HR form disclosing ownership of 0 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (US:NVO) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 267,933 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F NOVO-NORDISK A S ADR 670100205 0 -100.00 0
2025-08-14 2025-06-30 13F NOVO-NORDISK A S ADR 670100205 267,933 130,406 94.82 18,493 93.65 0.0369
2025-05-15 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 137,527 -30,668 -18.23 9,550 -34.00 0.0314
2025-02-14 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 168,195 61,040 56.96 14,468 13.40 0.0440
2024-11-14 2024-09-30 13F NOVO-NORDISK A S ADR 670100205 107,155 107,155 12,759 0.0378
2022-08-15 2022-06-30 13F Novo Nordisk A ADR 670100205 0 -1,897 -100.00 0 -100.00
2023-02-14 2022-03-31 13F/A-1 Novo Nordisk A ADR 670100205 1,897 1,897 211 0.0006
2022-05-13 2022-03-31 13F Novo Nordisk A ADR 670100205 1,897 1,897 211 0.0006
2021-05-14 2021-03-31 13F Novo Nordisk A ADR 670100205 0 -1,306 -100.00 0 -100.00
2021-02-12 2020-12-31 13F Novo Nordisk A ADR 670100205 1,306 62 4.98 91 5.81 0.0003
2021-02-11 2020-09-30 13F/A-1 Novo Nordisk A ADR 670100205 1,244 1,244 86 0.0003
2020-11-13 2020-09-30 13F Novo Nordisk A ADR 670100205 1,244 1,244 86
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.